Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake

On February 17, 2026, Commodore Capital disclosed in an SEC filing that it sold out its entire 3,200,000-share position in Viridian Therapeutics (NASDAQ:VRDN), an estimated $69.06 million transaction based on last-disclosed position values. What happened According to a filing with the Securities and Exchange Commission dated February 17, 2026, Commodore Capital reported selling its entire 3,200,000-share stake in Viridian Therapeutics. The net position change for the quarter was $69.06 million, reflectin ...